
Sortera Bio is a biotechnology company revolutionizing biologics discovery through its Deep Screening technology. This breakthrough platform generates massive sequence-function datasets from a single experiment, enabling the training of AI models with high-quality, unbiased real-world data. Their technology accelerates the discovery process by allowing comprehensive analysis of antibody libraries from various discovery methods, including in vitro, in vivo, and in silico, even targeting challenging membrane proteins. Sortera partners with leading companies to tackle complex biologics discovery challenges, positioning itself as a pioneer in AI-powered drug discovery with a scalable and innovative approach.

Sortera Bio is a biotechnology company revolutionizing biologics discovery through its Deep Screening technology. This breakthrough platform generates massive sequence-function datasets from a single experiment, enabling the training of AI models with high-quality, unbiased real-world data. Their technology accelerates the discovery process by allowing comprehensive analysis of antibody libraries from various discovery methods, including in vitro, in vivo, and in silico, even targeting challenging membrane proteins. Sortera partners with leading companies to tackle complex biologics discovery challenges, positioning itself as a pioneer in AI-powered drug discovery with a scalable and innovative approach.